The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Abbott Laboratories

NYSE: ABT
Last

(U.S.) $54.98

Today's change-0.72 -1.29%
Updated December 13 1:31 PM EST. Delayed by at least 15 minutes.
 

Abbott Laboratories

NYSE: ABT
Last

(U.S.) $54.98

Today's change-0.72 -1.29%
Updated December 13 1:31 PM EST. Delayed by at least 15 minutes.

Abbott Laboratories crosses below 50-day moving average

Abbott Laboratories is lower today, dropping (U.S.)$0.72 or 1.29% to (U.S.)$54.98 and crossing below its 50-day moving average. Over the last five days, shares have gained 0.59% and are currently 3.01% off of the 52-week high. Shares have outperformed the S&P 500 by 22.07% during the last year.

Key company metrics

  • Open(U.S.) $55.67
  • Previous close(U.S.) $55.70
  • High(U.S.) $55.76
  • Low(U.S.) $54.80
  • Bid / Ask(U.S.) $54.98 / (U.S.) $54.99
  • YTD % change+43.14%
  • Volume4,475,804
  • Average volume (10-day)6,308,474
  • Average volume (1-month)5,461,665
  • Average volume (3-month)5,449,903
  • 52-week range(U.S.) $37.90 to (U.S.) $56.69
  • Beta1.56
  • Trailing P/E45.33×
  • P/E 1 year forward22.32×
  • Forward PEG1.92×
  • Indicated annual dividend(U.S.) $1.06
  • Dividend yield1.93%
  • Trailing EPS(U.S.) $1.21
Updated December 13 1:31 PM EST. Delayed by at least 15 minutes.

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue6,8296,6376,3355,333
Total other revenue--------
Total revenue6,8296,6376,3355,333
Gross profit3,9723,4643,2913,023
Total cost of revenue2,8573,1733,0442,310
Total operating expense6,0196,2106,5374,385
Selling / general / administrative2,0802,1072,2991,606
Research & development493512541338
Depreciation / amortization501392522121
Interest expense (income), net operating--------
Unusual expense (income)882613110
Other operating expenses, total--------
Operating income810427-202948
Interest income (expense), net non-operating-218-214-226-153
Gain (loss) on sale of assets--------
Other--------
Income before tax626295736875
Income after tax561270386765
Income tax, total6525350110
Net income603283419798
Total adjustments to net income--------
Net income before extra. items561270386765
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items561270386765
Inc. avail. to common incl. extra. items603283419798
Diluted net income603283419798
Dilution adjustment--------
Diluted weighted average shares1,7541,7411,7351,484
Diluted EPS excluding extraordinary itemsvalue per share0.320.160.220.52
Dividends per sharevalue per share0.270.270.270.26
Diluted normalized EPSvalue per share0.360.170.260.52